AU2003210382A8 - Diagnostic for diseases associated with g-protein coupled receptor 105 (gpr105) - Google Patents
Diagnostic for diseases associated with g-protein coupled receptor 105 (gpr105)Info
- Publication number
- AU2003210382A8 AU2003210382A8 AU2003210382A AU2003210382A AU2003210382A8 AU 2003210382 A8 AU2003210382 A8 AU 2003210382A8 AU 2003210382 A AU2003210382 A AU 2003210382A AU 2003210382 A AU2003210382 A AU 2003210382A AU 2003210382 A8 AU2003210382 A8 AU 2003210382A8
- Authority
- AU
- Australia
- Prior art keywords
- gpr105
- diagnostic
- diseases associated
- coupled receptor
- protein coupled
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02005310.4 | 2002-03-13 | ||
EP02005310 | 2002-03-13 | ||
PCT/EP2003/002053 WO2003076945A2 (en) | 2002-03-13 | 2003-02-28 | Diagnostic for diseases associated with g-protein coupled receptor 105 (gpr105) |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2003210382A8 true AU2003210382A8 (en) | 2003-09-22 |
AU2003210382A1 AU2003210382A1 (en) | 2003-09-22 |
Family
ID=27798780
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003210382A Abandoned AU2003210382A1 (en) | 2002-03-13 | 2003-02-28 | Diagnostic for diseases associated with g-protein coupled receptor 105 (gpr105) |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003210382A1 (en) |
WO (1) | WO2003076945A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009070873A1 (en) * | 2007-12-04 | 2009-06-11 | Merck Frosst Canada Ltd. | Substituted 2-naphthoic acids as antagonists of gpr105 activity |
AU2014346641B2 (en) | 2013-11-07 | 2018-09-27 | The General Hospital Corporation | Compositions and methods for detecting and/or treating inflammation |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003524372A (en) * | 1998-05-01 | 2003-08-19 | スミスクライン・ビーチャム・コーポレイション | Screening method for agonists and antagonists of the interaction between human KIAA0001 receptor and its ligand |
US6773883B2 (en) * | 2000-07-31 | 2004-08-10 | The Brigham & Women's Hospital, Inc. | Prognostic classification of endometrial cancer |
-
2003
- 2003-02-28 WO PCT/EP2003/002053 patent/WO2003076945A2/en not_active Application Discontinuation
- 2003-02-28 AU AU2003210382A patent/AU2003210382A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2003076945A2 (en) | 2003-09-18 |
WO2003076945A3 (en) | 2004-06-03 |
AU2003210382A1 (en) | 2003-09-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL197774A0 (en) | Corticotropin releasing factor 2 receptor agonists | |
AU2003214072A1 (en) | Diagnostics and therapeutics for diseases associated with the n-formyl peptide receptor 1 (fpr 1) | |
AU2003210382A8 (en) | Diagnostic for diseases associated with g-protein coupled receptor 105 (gpr105) | |
AU2003273994A8 (en) | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 43 (gpr43) | |
AU2003240589A1 (en) | Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 4 (gpr4) | |
AU2003229767A8 (en) | Diagnostics and therapeutics for diseases associated with chemokine receptor 9(ccr9) | |
AU2003240720A1 (en) | Diagnostics and therapeutics for diseases associated with somatostatin receptor 5 (sstr5) | |
AU2003294206A8 (en) | Methods for diagnosing htlv-i-mediated diseases | |
AU2003250128A1 (en) | Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 37 (gpr37) | |
AU2003276106A8 (en) | Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 12 (gpr12) | |
AU2003206749A1 (en) | Diagnostics and therapeutics for diseases associated with the gpr65 receptor | |
AU2003250165A1 (en) | Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 19 (gpr19) | |
AU2003246726A1 (en) | Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 45 (gpr45) | |
AU2003240721A1 (en) | Diagnostics and therapeutics for diseases associated with somatostatin receptor 4(sstr4) | |
AU2003274005A1 (en) | Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 6 (gpr6) | |
AU2003301892A8 (en) | Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 3 (gpr3) | |
AU2003221502A8 (en) | Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 10 (gpr10) | |
AU2003267443A1 (en) | Diagnostics and therapeutics for diseases associated with human g protein-coupled receptor 41 (gpr41) | |
GB0215389D0 (en) | Receptor | |
AU2003227751A1 (en) | Diagnostics and therapeutics for diseases associated with arginine vasopressin receptor 1 (avpr1) | |
AU2003240639A1 (en) | Diagnostics and therapeutics for diseases associated with arginine vasopressin receptor 3 (avpr3) | |
AU2003240736A1 (en) | Diagnostics and therapeutics for diseases associated with somatostatin receptor 2 (sstr2) | |
AU2003229736A1 (en) | Diagnostics and therapeutics for diseases associated with neurotensin receptor 1 (nt1) | |
AU2003266238A8 (en) | Diagnostics and therapeutics for diseases associated with ovarian cancer g-protein coupled receptor 1 (ogr-1) | |
AU2003213801A8 (en) | Toll-like receptor 11 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |